MUC2 and ovarian benign neoplasm: To differentiate the overexpression status of MUC2 from its baseline expression, we performed a parallel immunohistochemical experiment on 33 benign ovarian tumor specimens (methods for collecting these specimens were provided by Materials and Methods S1 in File S1; demographic and pathological characteristics of the 33 patient were provided by Table S1).